![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 19, 16376-16382, May 10, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Centre for Neurobiochemistry, Department of Biological
Sciences, Imperial College of Science, Technology and Medicine,
London SW7 2AY, United Kingdom
Received for publication, October 8, 2001, and in revised form, February 14, 2002
Most neuronal Kv1 channels contain Kv1.1, Kv1.2
Voltage-gated K+ channels are involved in the
maintenance of resting membrane potential and control of action
potential frequency and threshold of excitation (1). Members of the
Shaker-related subfamily (Kv1) are sialoglycoprotein complexes
(Mr ~400,000) consisting of four transmembrane
channel-forming Authentic Kv1 channel proteins were first identified (11) using Herein, Construction of Monomeric, Dimeric, and Tetrameric
cDNAs--
All constructs were incorporated into p
To prepare a Kv1.2N-1.1C chimera, the
N-terminal region of Kv1.1 (487 bp) was replaced with the equivalent
domain of Kv1.2 (475 bp). p Electrophysiological and Biochemical Analysis of Recombinant
K+ Channels--
Oocytes were isolated from mature
Xenopus laevis females (Xenopus I, Blades) and
injected with Kv1.1 or 1.2 cRNA, as described by Main et al.
(25). K+ currents were recorded after 72 h, using a
two-microelectrode voltage clamp amplifier (TEC-03; NPI) as
described previously (26) during voltage steps to +20 mV from a holding
potential of
Channels were expressed in BHK cells and analyzed in the native state
by gel filtration, or by SDS-PAGE and Western blotting as described
previously (10). Saturable binding of 125I-labeled Voltage Activation of K+ Channel Subtypes Prominent in
Neurons Is Varied by Predetermining Their Content of Kv1.1 and Kv1.2
Subunits--
Recreation of Recombinant K+ Channels with Homomeric Kv1.1 and Kv1.2 Channels Show Different Affinities for
DTXk and One Kv1.1 Subunit in K+ Channel Oligomers Confers Near
Maximal DTXk Binding Affinity and Sensitivity of Their
K+ Currents to Blockade--
Decreasing the number of
Kv1.1 subunits in oligomers from four to one caused minimal reduction
in their affinity for 125I-DTXk; the
KD values dropped only 2- and 3-fold, respectively, for Kv(1.1-1.2)2 and Kv1.1-(1.2)3 (Table II).
Likewise, the modest changes in the Ki values (Fig.
4G) for DTXk antagonizing 125I-DTXk binding to the latter oligomers
relative to that for Kv(1.1)4 support the above deduction.
These binding data were corroborated by the DTXk
sensitivities of the channels when expressed in oocytes; the
IC50 values of the Kv(1.1-1.2)2 and
Kv1.1-(1.2)3 K+ currents are only 2- and 9-fold
lower than that for Kv(1.1)4 (Table I). Thus, based on both
toxin binding and functional blockade, one copy of Kv1.1 is adequate to
bestow near maximal affinity for DTXk and susceptibility to
inhibition (see "Discussion").
Moreover, behavior of the channels in binding 125I-
Finally, it is noteworthy that not only can the two toxins discriminate
channel subtypes, but the Bmax values for Successful Recreation of the Most Abundant Kv1 Heteromultimers in
Mammalian Neurons--
Kv1.1-, Kv1.2-, and Kv Increasing the Number of Kv1.1 Subunits in a Tetramer Gave
Commensurate Changes in the Voltage Dependence of Activation of the
K+ Currents--
The tetramers containing varying ratios
of Kv1.1 and Kv1.2 gave slowly inactivating, outward currents with
distinct voltage dependences of activation that differed from either
parent. The V1/2 values were slightly skewed toward that of
Kv1.1, which may be due to the effect of Kv1.1 upon activation (29,
30). However, the V1/2 values also clearly reflect the
influence of both parental subunits. Establishing the presence of both
Kv1.1 and Kv1.2 in this way in the expressed channels constructed by
tandem linkage of subunits in the oligomers afforded exploitation of
the predetermined stoichiometries for the subsequent toxin block and
binding studies.
A Single Kv1.1 Subunit in Tetramers Containing Kv1.2 Creates High
Affinity Functional Interaction with DTXk--
Both
saturable binding and competition analysis using intact BHK cells and
inhibition of the K+ currents in oocytes confirmed that one
Kv1.1 subunit in an oligomer is enough to confer a high affinity
interaction with DTXk and blockade of the currents. This
conclusion from measurements on defined populations of native-like
subtypes accords with a deduction from functional studies on
biochemically uncharacterized channels, namely, that a single
toxin-sensitive subunit can give K+ currents susceptibility
to DTXk homologues (6). Mutagenesis of DTXk has
shown that two domains, 310 helix and
Notably, a single high affinity site for DTXk was observed
regardless of the number of Kv1.1 subunits, whereas synaptic membranes show a high affinity and low affinity binding site (31). The retention
of high affinity for DTXk by Kv1.1 channels with up to
three insensitive Kv1.2 subunits provides good evidence for the lower
affinity site being due to multimerization with other subunits
(e.g. Kv1.4, Kv1.3, or Kv1.6) known to be associated with
Kv1.1 (13-15, 19) that may result due to steric hindrance. Because
Kv(1.1)4 does not exist in normal human brain (14), and a
majority of native K+ channels containing Kv1.2 also have
Kv1.1 (50%) (13, 17), the latter must represent the bulk of the higher
affinity DTXk sites (31) and thus could explain the
overlapping location of DTXk and Kv1.1 Channels Apparently Have More Sites for Functional Properties of the Recombinant Channels in Relation to
Those of Neuronal K+ Currents in Health and
Disease--
Because Kv1.1 and 1.2 subunits exhibit distinct
properties, it is not surprising that changing their ratios resulted in
K+ currents with unique electrophysiological and
pharmacological properties. The profiling of their characteristics
ought to help molecular entities to be ascribed to the native
K+ channels, a feat not feasible to date. Thus, properties
of the recombinant channels were compared with the two types of
DTX-sensitive, sustained K+ currents recorded in neuronal
cells. Our data for Kv(1.1-1.2)2 and
Kv1.1-(1.2)3 indicate that they resemble a DTX-sensitive, low-threshold current (IDS) in various neurons
that activates within
These properties derived from channels encompassing most combinations
of Kv1.1/1.2 give new insights into the molecular basis of the symptoms
seen in patients suffering from episodic ataxia I/myokymia (22, 23).
Because we demonstrated herein that these channels' biophysical
parameters show gradual changes proportional to their content of Kv1.1
subunits, and a variety of human mutations are known to alter the
properties of Kv1.1 homomers (23), the diversity of abnormalities in
different cases supports the existence of several hetero-oligomeric
combinations of mutated and wild-type Kv1.1, together with Kv1.2; note
that Kv(1.1)4 does not occur in human neurons (14). Such
subtypes would exist in different locations, neurons, or compartments
(e.g. nerve terminals, axons, and so forth) where each
normally serves a pivotal role; thus, a spectrum of abnormalities in
individual patients is likely to be due to different stoichiometries of
Kv1.2, Kv1.1, and a variant that could be mutated at one of several
residues (22, 23). Importantly, the major advance accomplished herein
will allow elucidation of the modified properties of all these channel
forms constructed by tandem linking Kv1.1, its distinct mutants, and Kv1.2 in the various stoichiometries, followed by co-expression with
Kv We thank Dr. M. Main at Glaxo-Smith-Kline for
help with some recordings from oocytes.
*
This work was supported by a Wellcome Trust grant (to
J. O. D.) and a BBSRC CASE studentship in cooperation with
Cambridge Drug Discovery (to F. A.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, February 21, 2002, DOI 10.1074/jbc.M109698200
The abbreviations used are:
DTX, dendrotoxin;
SFV, Semliki Forest virus;
BHK, baby hamster kidney.
Characteristics of Brain Kv1 Channels Tailored to Mimic Native
Counterparts by Tandem Linkage of
Subunits
IMPLICATIONS FOR K+ CHANNELOPATHIES*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
, and Kv
2.1 subunits, yet the influences of their stoichiometries
on properties of the (
)4(
)4
variants remain undefined. cDNAs were engineered to contain 0, 1, 2, or 4 copies of Kv1.1 with the requisite number of Kv1.2 and
co-expressed in mammalian cells with Kv
2.1 to achieve "native-like" hetero-oligomers. The monomeric (Kv1.1 or 1.2), dimeric (Kv1.1-1.2 or 1.2-1.2), and tetrameric
(Kv1.1-(1.2)3) constructs produced proteins of
Mr ~62,000, 120,000, and 240,000, which assembled into (
)4(
)4 complexes.
Each
cRNA yielded a distinct K+ current in oocytes,
with voltage dependence of activation being shifted negatively as the
Kv1.1 content in tetramers was increased. Channels containing 1, 2, or
4 copies of Kv1.1 were blocked by dendrotoxin k (DTX)k with
similarly high potencies, whereas Kv(1.2)4 proved
nonsusceptible. Accordingly, Kv1.2/
2.1 expressed in baby hamster
kidney cells failed to bind DTXk; in contrast, oligomers containing only one Kv1.1 subunit in a tetramer exhibited high affinity, with additional copies causing modest increases. Thus, one
Kv1.1 subunit largely confers high affinity for DTXk,
whereas channel electrophysiological properties are tailored by the
content of Kv1.1 relative to Kv1.2. This notable advance could
explain the diversity of symptoms of human episodic ataxia I, which is often accompanied by myokymia, due to mutated Kv1.1 being assembled in
different combinations with wild-type and Kv1.2.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
subunits (Kv1.1-1.6) and four cytoplasmic
regulatory
(Kv
1-3) proteins (Ref. 2; reviewed in
Ref. 3). Heterologously expressed Kv1 members assemble via their
N-terminal domain (NAB) (4) into homo- or heteromultimeric channels
with distinct electrophysiological and pharmacological properties (3,
5, 6), although the subunit stoichiometries in the plasmalemma used for
the recordings have not been determined. Co-expression of
Kv
1 or Kv
3 with Kv1
subunits
accelerates inactivation of the K+ currents (2, 7), whereas
Kv
2 increases surface expression (8-10).
and
k/dendrotoxin (DTX)1;
DTX
is less discriminating and inhibits Kv1.2 > Kv1.1 > Kv1.6 currents, whereas DTXk is more stringent and specifically
blocks Kv1.1 channels (12). Sequential immunoprecipitation, using
subunit-specific antibodies, and affinity chromatography on immobilized
DTX and/or DTXk (13-16) unveiled a limited repertoire
of subtypes, ranging from Kv(1.2)4 to those containing
Kv1.1/1.2, Kv1.1/1.2/1.6, Kv1.2/1.3/1.4/1.6, or Kv1.1/1.2/1.3/1.4.
Also, data from immunocytochemistry and immunological analysis
established that Kv1.1, Kv1.2, and Kv
2.1 are the most abundant
subunits found together in channel complexes (14, 15, 17, 18). These
subunits are co-localized in the juxta-paranodal region of the nodes of
Ranvier, as well as in the axons and terminals of cerebellar basket
cells of rat brain (19). Thus far, heterologous expression of Kv1
and
subunits has failed to mimic the characteristics of neuronal
K+ currents, highlighting the need to reproduce native
K+ channels. Additionally, certain neurological conditions
are associated with changes in Kv1 channel multimers. For example, an
increase in the number of
DTX binding sites occurs in demyelinated
brain plaques from patients with multiple sclerosis (20), whereas the
content of
DTX and DTXk acceptors is decreased in
hippocampus from aging patients or those with Alzheimer's disease
(21). Furthermore, several mutations in Kv1.1 are associated with human disorders (e.g. episodic ataxia I and myokymia) (1, 22, 23), whereas mutations in certain other genes can distort expression and
localization of Kv1.1 and 1.2, thereby inducing abnormal phenotypes (e.g. mouse strains Trembler and Shiverer) (24).
subunits were tandem-linked to recreate subtypes with
predefined stoichiometries for Kv1.1 and 1.2 and to quantitatively relate subunit composition to channel properties. Functional
K+ channels containing different numbers of Kv1.1
co-assembled with Kv1.2 in the presence of Kv
2.1 were generated
using Semliki Forest virus (SFV), yielding oligomers resembling those
prevalent in neurons. Electrophysiological recording of their
respective K+ currents in oocytes and analysis of the
binding of 125I-labeled DTXk and
DTX to
transfected mammalian cells revealed that varying proportions of Kv1.1
and 1.2 could subtly influence the biophysical and pharmacological
properties of expressed channels. Such systematic profiling should
allow identification of K+ channel counterparts in neurons
and their altered phenotypes in diseases.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
ut2pA for
high expression in Xenopus oocytes (9). Monomeric cDNAs
were prepared by PCR amplification of rat Kv1.1 and 1.2 subunits, using
the respective primer pairs (a)
5'-CCCTCGAGCCACCATGGCGGTGATG-3' and 5'-CTGGTCGACTTTTTAAACATCGGT-3' and (b) 5'-
ACTCCTCGAGCACCATGGCAG-3' and
5'-AATAGGTCGACATCAGACATCAGT-3' to introduce XhoI
and SalI sites (underlined) with pAKS Kv1.1 or
1.2 cDNA as template (a gift from Prof. O. Pongs). After digestion,
the products were ligated into p
ut2pA similarly cleaved. The
Kv1.2-1.2 construct was obtained by joining together the two cDNAs
via the 5'-untranslated region of the Xenopus
-globin
gene. For the first position in this tandem, Kv1.2 was amplified from
pAKS using primers 5'-CTGCAACTAGTATGACGGTGATGTCAGGGG-3' and
5'-CAACTCGAGATCAGTTAACATTTTGGTAA-3' to remove the stop
codon and introduce SpeI and XhoI sites
(underlined). After digestion, the PCR product was ligated
into p
ut2pA vector cut with XbaI and XhoI to
generate p
ut2pA Kv1.2 (without stop codon). To introduce the second
constituent of the dimer, a His6 tag was inserted at the C
terminus of Kv1.2, and its initiation codon was removed by PCR to give
p
ut2pA Kv1.2 (+His6,
ATG). The latter was amplified using the primer pair 5'-TTTGTCGACACTCAGAAAGAAACGCTC-3'
(sense) and 5'-CGTAATACGACTCACTATAGGGC-3' (antisense). After
digestion with SalI (introduced by sense primer) and
EcoRI (present downstream of coding sequence), the fragment
was subcloned into p
ut2pA Kv1.2 (without stop codon) cut with
XhoI and EcoRI to generate p
ut2pA Kv1.2-1.2
(+His6,
ATG, 16-amino acid linker, and a stop codon). p
ut2pA Kv1.1-1.2 was designed on the same principle. The coding sequence of rat Kv1.1 was PCR-amplified from pAKS Kv1.1 cDNA using the primer pair 5'-CTGCAACTAGTATGACGGTGATGTCAGGGG-3'
(sense) and 5'-CTGGTGCTTCTCGAGAACATCGGTCAGGAG-3'
(antisense) to exclude the stop codon and introduce
SpeI and XhoI sites (underlined). The digested product was ligated into p
ut2pA (XbaI and
XhoI) to generate p
ut2pA Kv1.1 (without stop codon). This
was cleaved (XhoI and EcoRI), and the
PCR-amplified Kv1.2 (+His6,
ATG) fragment was subcloned
downstream of Kv1.1 cDNA, after cutting with SalI and EcoRI. p
ut2pA Kv1.1-(1.2)3 was obtained by
joining Kv1.2-1.2 downstream of Kv1.1-1.2 after manipulations of the
two constructs. A His6 sequence and stop codon were removed
from the C terminus of the heterodimer and ligated in-frame to
homodimer after deletion of ATG from the first Kv1.2 cDNA to yield
p
ut2pA Kv1.1-(1.2)3.
ut2pA Kv1.1 and 1.2 plasmids were
digested with HindIII (outside the coding region) and
SacI (487 or 475 bp downstream of Kv1.1 and 1.2, respectively). The isolated larger (~4500 bp from p
ut2pA Kv1.1)
and smaller (~475 bp from p
ut2pA Kv1.2) fragments were ligated to
yield p
ut2pA Kv1.2N-1.1C. Every construct
made above was verified by restriction digestion and dideoxy DNA
sequencing. For expression in the SFV system, all Kv1 p
ut2pA
constructs were subcloned into pSFV1 vector, employing
HindIII and BglII sites to cut out the cDNA
fragments that were blunt-ended before ligation with pSFV1 vector (10).
cRNAs for each Kv1 construct (in p
ut2pA and pSFV1) and pSFVH1
(plasmid encoding viral packaging proteins) were prepared as described
previously (10).
80 mV. DTXk was applied by superfusion (at a
rate of 5 ml/min), and its concentration increased cumulatively.
Addition of tetraethylammonium chloride (0.1-100 mM) was
made with substitution of NaCl to maintain ionic strength. A membrane
fraction from the injected and noninjected oocytes was analyzed by
SDS-PAGE.
DTX
and DTXk to intact cells expressing the various constructs
was measured in triplicate under established conditions (10) by rapid
filtration through GF/F glass microfiber filters that had been
presoaked in 0.5% (v/v) polyethyleneimine. The radioactivity associated with the washed filters was quantified by
-radiation counting; data presented (±S.E.) were analyzed using the Graph Pad
software (Prism 3.0) based on a one-site model.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Subunit stoichiometries were predefined by linking
their cDNAs in an open reading frame (Fig.
1), using a 16-amino acid sequence from
5'-untranslated region of the Xenopus
-globin gene. In
this way, the expressed Kv1.2-1.2 or Kv1.1-1.2 should assemble into
the desired tetrameric proteins, Kv(1.2-1.2)2 and
Kv(1.1-1.2)2, respectively, whereas the third construct
would yield a channel consisting of one Kv1.1 subunit and three Kv1.2
subunits. Biochemical evidence was obtained for formation of the
expected oligomers in oocytes, to validate the data subsequently
obtained from electrophysiological analysis of the K+
currents. Injection into oocytes of cRNAs for the p
utpA Kv1 constructs followed by Western blotting demonstrated that Kv1.1 and
Kv1.2 cRNAs were translated into single subunits of
Mr ~60,000-64,000, whereas the dimers and
tetramer gave proteins with Mr ~120,000 and
Mr 240,000, respectively (Fig.
2A). A two-electrode voltage clamp was used to establish the effects of varying the ratio of Kv1.1
and Kv1.2 in expressed tetramers. Because Kv
2.1 has no appreciable
effect on activation of Kv1.1 and Kv1.2 channels (26), it was omitted.
Oocytes injected with equivalent amounts of cRNAs encoding each of the
constructs yielded 1-10 µA K+ currents after 72 h,
establishing that the expressed proteins were inserted into the
plasmalemma as functional channels. Kv1.1, Kv1.2, Kv1.1-1.2,
Kv1.2-1.2, and Kv1.1-(1.2)3 gave outward noninactivating K+ currents with characteristic voltage dependences (Fig.
2, B and C). Kv1.2 and Kv1.2-1.2 (homodimer)
K+ currents exhibited a similar voltage dependence of
activation (Table I) (threshold =
45 to
40 mV) and half-maximal activation voltage (V1/2 =
15.1 and
16.97 mV); the slope (k) values of 10.8 and
8.3, respectively, confirmed the near-identical activation kinetics.
Therefore, the linker does not exert a significant influence. Kv1.1
elicited a fast-activating, slow-inactivating K+ current
that had a more negative activation threshold (
60 to
50 mV) than
Kv1.2 (Fig. 2, B and C) and V1/2 =
30.8
mV; these values for the homomeric channels are sufficiently different
to allow them to be distinguished reliably. The heterodimer Kv1.1-1.2
cRNA yielded a current that had properties distinct from either parent
(Fig. 2, B and C); interestingly, this showed a
greater resemblance to Kv1.1 than Kv1.2 current (Table I), with an
activation threshold between
55 and
50 mV and a V1/2 =
26.5 mV. Despite this, the Kv1.1-1.2 K+ current proved
much less susceptible to blockade by external tetraethylammonium
(IC50 = 100 mM) than Kv1.1 (IC50 < 1 mM). A delayed rectifying K+ current was
observed with Kv1.1-(1.2)3 (Fig. 2B),
activating at a threshold of
55 to
50 mV (Table I); also, its
V1/2 fell between that for the channels made from Kv1.1-1.2
and Kv1.2-1.2 or Kv1.2 constructs (Fig. 2C; Table I), and
had a slope similar to the other channels. Thus, Kv1.1 exerts a more
dominant influence on K+ channel activation, with
V1/2 shifting negatively upon increase in the number of Kv1.1
subunits; on the other hand, their slope factors (k),
an indication of activation kinetics, are similar, as expected, because
the slope values for the parents are close.

View larger version (29K):
[in a new window]
Fig. 1.
Schematic representation of K+
channels translated from the different constructed cDNAs.
A, the putative membrane topology of the expressed chimeric
protein translated from a cDNA construct made by fusing the
N-terminal region of Kv1.2 (1-475 bp) to the coding sequence of Kv1.1
from which the corresponding region had been deleted (1-486 bp). The
dotted line represents the N terminus of Kv1.2, whereas the
solid line and barrels, which illustrate the six
transmembrane domains, are from Kv1.1. B, cDNAs encoding
the homodimer and heterodimer were prepared by linking in tandem the C
terminus of Kv1.1 or Kv1.2 (without stop codon) with the N terminus of
Kv1.2 via a hydrophilic linker containing 16 amino acids
(DTQKETLNFGRSTLEI), whereas the heterotetramer was made by linking the
C terminus of heterodimer (without stop codon) to the N terminus of
homodimer. The circles show the possible relative positions
of the Kv1.1 (
) and Kv1.2 (
) subunits in tetramers after
translation from each construct. The bars represent linker;
noncovalent associations between subunits in tetramers are not
depicted.

View larger version (42K):
[in a new window]
Fig. 2.
Analysis of molecular and
electrophysiological properties of the different K+
channels expressed in oocytes A, Xenopus
oocytes were injected with the individual cRNAs (~5 ng) and incubated
at 16 °C for 48 h, and their crude membranes (lanes
1-3 and 6-8), along with synaptic membranes
(lane 4), were subjected to SDS-PAGE (left panel,
9% gel; right panel, 6% gel). After transfer onto
polyvinylidene difluoride, the membranes were blocked with 5% (w/v)
dried milk before overnight incubation with monoclonal anti-Kv1.2
(lanes 1-5; 1:1000 dilution) or rabbit polyclonal
anti-Kv1.1 (lanes 6-8; ~1 µg IgG/ml) and detection with
the ECL system. Lane 1, Kv1.2-1.2; lane 2,
Kv1.1-1.2; lane 3, Kv1.2; lane 6, Kv1.1-1.2;
lane 7, Kv1.1; lane 8, Kv1.1-(1.2)3.
Neither Kv1.2 (lane 5) nor Kv1.1 (data not shown) was
detectable in the controls injected with water. B,
K+ currents were recorded from oocytes 72 h after
injection with cRNAs encoding Kv1.1 (I), Kv1.2
(II), Kv1.2-1.2 (III), Kv1.1-1.2
(IV), or Kv1.1-(1.2)3 (V). Voltage
dependence of activation was measured by voltage pulses of 400 ms in duration, from a holding potential of
80 mV to +40 mV in 10-mV
increments (VI). C, activation curves plotted,
using a simple Boltzmann function, as the mean conductances (± S.E.)
for each construct (Kv1.1 (
), 1.2 (
), 1.2-1.2 (
), 1.1-1.2
(
), and 1.1-(1.2)3 (
)) gave the V1/2 and
slope values (k) in Table I.
Activation parameters and blockade by DTXk of K+
channels expressed in oocytes using Kv1.1, Kv1.2, and their tandem
constructs
/
Subunit Stoichiometries Mimicking Major Subtypes in Brain--
To
generate adequate amounts of the recombinant channels for biochemical
analysis, pSFV1 Kv1.1, Kv1.2, Kv1.1-1.2, or Kv1.1-(1.2)3 was expressed in BHK cells to generate four oligomers representing the
majority of possible combinations of the most abundant subunits found
in central neurons. The expression level was elevated by inclusion of
Kv
2.1, which promotes cell surface targeting; to obtain adequate
quantities of the poorly expressed Kv(1.1)4 (10), the
N-terminal part was replaced with an analogous moiety of Kv1.2 that
regulates the efficiency of assembly (see "Introduction"). This
construct gave increased surface expression in BHK cells (~2-fold
relative to the unmodified Kv1.1), yielding a subunit of the expected
Mr ~60,000-62,000 on immunoblotting (Fig.
3A). The dimer was twice this
size and was recognized by both anti-Kv1.1 and anti-Kv1.2 antibodies
(Fig. 3, A
C), confirming the presence of both
subunits. Kv1.1-(1.2)3 construct gave a protein of the expected molecular weight (240,000) that was also reactive with anti-Kv1.1 and anti-Kv1.2 antibodies (Fig. 3, B and
C). Thus, the dimer and tetramer cRNAs were correctly and
fully translated, without any detectable proteolytic breakdown
products; importantly, the channels were correctly assembled and
inserted into the plasmalemma and functional (Table
II; detailed later). Direct
evidence for the formation of
/
subunit oligomers was provided by
the oligomeric sizes of the channels extracted from BHK cells in
nondenaturing detergent obtained from gel filtration on Superose 6HR
(Fig. 3D); the similar elution position for the monomer,
dimer, and tetramer expressed with Kv
2.1 gave an apparent molecular
weight for the oligomer-detergent complex of ~515,000 (Fig.
3D, inset). Because this value is very similar to
the size for Kv(1.2)4(
2.1)4 (10), it can be
concluded that all the Kv1 constructs produced proteins that assembled
into tetramers containing four
and four
subunits, as observed
for neuronal K+ channel complexes (27).

View larger version (26K):
[in a new window]
Fig. 3.
Analysis at the subunit and oligomeric levels
of the K+ channels expressed using SFV. Cells (~50
µg of protein) infected with SFV encoding chimeric Kv1.1
(A, lane 1), dimeric Kv1.1-1.2 (A,
lane 2; B and C, lane 1),
or tetrameric Kv1.1-(1.2)3 constructs (B and
C, lane 2) were subjected to SDS-PAGE using 9%
(A) or 6% gels (B and C) for better
resolution and detected as described in Fig. 1A using
the antibodies specified. D, another sample was detergent
solubilized and chromatographed (10). Fractions were dot-blotted onto
polyvinylidene difluoride membrane, with visualization as described in
Fig. 1A using anti-Kv1.1 and anti-Kv1.2 IgGs; blots of the
peak fractions are shown (inset). The column was calibrated
with thyroglobulin, ferritin, catalase, and
-amylase; the
arrow indicates the common elution position of the
K+ channels.
Binding of 125I-DTXk or 125I-
DTX to various
K+ channels co-expressed with Kv
2.1 in BHK cells and the
toxins' mutual antagonism
DTX; Their K+ Currents Exhibit
Corresponding Susceptibilities to DTXk--
BHK cells
expressing Kv(1.2)4 proved unable to bind
125I-DTXk (Table II); accordingly, the
K+ current generated in oocytes was insensitive to blockade
by 100 nM DTXk (Table I). In contrast,
Kv(1.1)4 displayed high affinity for
125I-DTXk (Fig.
4A; Table II), consistent with
its K+ current in oocytes being inhibited by low
concentrations of DTXk (Table I). An avid interaction was
reaffirmed for the latter channel by the Ki values
of DTXk competing for the binding of
125I-DTXk (Fig. 4G) and
125I-
DTX (Fig. 4I). Comparison of the binding
of both toxins to Kv(1.1)4 showed that
125I-
DTX displayed a 12-fold lower affinity than
125I-DTXk (Table II). On the other hand,
125I-
DTX exhibited a ~5-fold higher affinity for
Kv(1.2)4 than Kv(1.1)4 (Table II), in agreement
with
DTX blocking Kv1.2 K+ current with greater potency
than Kv1.1 or Kv1.6 (5).

View larger version (32K):
[in a new window]
Fig. 4.
125I-DTXk and
125I-
DTX binding to intact BHK
cells expressing the constructed K+ channels: competition
with DTXk and
DTX.
Suspensions of BHK cells expressing chimeric Kv(1.1)4
(A and D), Kv(1.1-1.2)2
(B and E), or Kv1.1-(1.2)3
(C and F) were incubated with
125I-DTXk (A
C) or
125I-
DTX (D
F) at 22 °C for 45 min. In A
F, nonsaturable binding (
)
was determined in the presence of 1 µM of the requisite
unlabeled toxin and subtracted from the total (
) to give the
saturable component (
). For the competition experiments
(G
I), cells expressing chimeric
Kv(1.1)4 (
), Kv(1.1-1.2)2 (
), and
Kv1.1-(1.2)3 (
) were incubated with 1 nM
125I-DTXk in the absence
(B0) and presence of DTXk
(G) or
DTX (H). In I, 1 nM 125I-
DTX was used with
Kv(1.1)4 (n), Kv(1.1-1.2)2
(s), and Kv1.1-(1.2)3 (
) channels, with or
without DTXk. Values for nonsaturable binding, measured in
the presence of 1 µM DTXk or
DTX, have
been subtracted from the means (± S.E.) of triplicate values
plotted.
DTX
gave a similar trend with no major difference in the
KD or Ki values upon increasing
the number of copies of Kv1.2 in the
(
)4(
)4 multimers (Table II). Likewise,
the similar Ki values for
DTX antagonizing
125I-DTXk binding to Kv(1.1-1.2)2
and Kv1.1-(1.2)3 (Fig. 4H) revealed that two
Kv1.2 subunits are sufficient for binding
DTX with high affinity.
Because
DTX has a lower affinity for Kv(1.1)4 than DTXk, it proved significantly less potent in antagonizing
125I-DTXk binding, but this was increased
substantially (14-34-fold) when Kv1.2 subunits were introduced to the
channels (Fig. 4H). As expected, DTXk was less
effective in displacing 125I-
DTX from Kv1.2-containing
multimers than Kv(1.1)4 (Fig. 4I).
DTX
were 2-3-fold higher than for DTXk in the same batch of
BHK cells (Table II; see "Discussion").
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
2.1-containing
oligomers predominate in brain (13, 17); Kv(1.2)4 is also
present, but Kv1.1 always occurs in association with other
members (14, 15). Due to their abundance and functional
importance (see "Introduction"), we profiled the characteristics of
those with several different proportions of Kv1.1 and Kv1.2 to
encompass the subtypes found in neurons. All the linked Kv1 subunits
were expressed in both amphibian and mammalian cells as single, intact
proteins without premature translation or degradation products. Their
functionality was documented by the K+ currents recorded
after expression in oocytes, with characteristics matching those
expected. When co-expressed with Kv
2.1, each channel co-assembled
into (
)4(
)4 complexes and was inserted
correctly into the plasma membrane of BHK cells, as established from
measurement of high affinity binding of DTXk and
DTX,
which require
subunits to be assembled into tetramers (28).
-turn, that are 14 Å apart contribute to interaction with possibly two adjacent channel
subunits (31). Notably, the 310 helix is essential for both
high affinity binding of DTXk to Kv1.1 and precluding its interaction with other subunits; in contrast, the
-turn seems less
important for recognition of Kv1.1 (31). Hence, it was suggested that
the latter region could interact with a different subunit of the
K+ channels in synaptic membranes; in the present study,
this would be another Kv1.1 or Kv1.2. Thus, the slightly lower
DTXk affinity for Kv(1.1-1.2)2 and
Kv1.1-(1.2)3 compared with Kv(1.1)4 may be attributed to a reduction in the number of sites for interaction with
the 310 domains and/or a decrease in the affinity of
-turn for the adjacent subunit (i.e. Kv1.2 instead of
Kv1.1). With two copies of Kv1.1 and Kv1.2, a significant increase in
DTXk affinity was not observed, possibly because of its
access being restricted due to the two Kv1.1 in some of the oligomer
being positioned diagonally rather than adjacently (Fig.
1B).
DTX acceptors in rat
brain (32).
DTX than
DTXk--
The Bmax for
DTX
binding sites was always 2-3-fold higher than that for
DTXk in the same batches of cells. This intriguing finding
can possibly be explained by structural elements of DTXk,
DTX (96% homologous to DTXk), and
DTX.
Similar residues (e.g. Lys-3/6 and Lys-26) in the two
domains (310 helix and
-turn), equivalent to those
important for DTXk recognition of rat Kv1.1-containing channels (31, 33), have also been identified from scanning mutagenesis
and thermodynamic mutant cycle analysis in
DTX (34). Mutation of the
ShaKv1.1 channel revealed that
DTX binds at some distance
from the pore, involving Lys-3 and Arg-10 among other residues; these,
with Lys-26, form a triangle whose vertices are 20 Å apart. This
distance would allow interaction with adjacent subunits through Lys-3,
Arg-10 (34), and/or Lys-26 (31). However, mutations in the Shaker
chimeric channel did not yield evidence for a contribution of Lys-26 to
the strong interaction, possibly because it binds residues not
substituted that form part of the DTX acceptor site (35, 36). On the
other hand, residues at the N terminus of
DTX are most influential
for Kv1 interaction (37) and are equivalent to the essential amino
acids in the 310 helix of DTXk, although
DTX
lacks such a secondary structural feature; this could underlie its less
stringent specificity. Furthermore, the contributions of
-turn
residues in
DTX are less pronounced than that for DTXk
(33, 37). Based on the collective findings, DTXk appears to
interact with two Kv1 subunits, whereas
DTX requires predominantly
one interactive domain; hence, twice as many
DTX molecules might be
able to bind each tetramer, or perhaps not all the channels are
folded perfectly and therefore cannot accommodate the stringent
requirements for DTXk binding.
50 to
60 mV and prevents repetitive firing
(38, 39). Because Kv1.1 and Kv1.2 are the major subunits known to give
sustained outward K+ currents that are highly sensitive to
DTX, their combinations must be responsible for such current
phenotypes. Gold et al. (40) have described a similar
current (IKit) in rat sensory neurons that may
relate to a DTXk-susceptible current found in the same preparation (41); as with the currents we observed,
IKit activates at low thresholds and is fully
activated by +20 mV. From the results herein, it seems that one Kv1.1
subunit in an oligomer with Kv1.2 would be sufficient to give such
voltage sensitivity and DTXk susceptibility; moreover, the
slowly inactivating nature of the currents excludes the presence of
Kv1.4 and thereby implicates either Kv1.1/1.2 or Kv1.1/1.2/1.6
(15).
2.1. Although this strategy has already been found to be
informative for dimers of normal and mutated Kv1.1 (42), creating the
authentic
/
combinations should prove much more pertinent.
![]()
ACKNOWLEDGEMENT
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of Biological
Sciences, Imperial College of Science, Technology and Medicine, Exhibition Rd., South Kensington, London SW7 2AY, United Kingdom. Tel.:
44-20-75945243; Fax: 44-20-75945312; E-mail: o.dolly@ic.ac.uk.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Lehmann-Horn, F.,
and Jurkat-Rott, K.
(1999)
Physiol. Rev.
79,
1317-1372 2.
Heinemann, S. H.,
Rettig, J.,
Wunder, F.,
and Pongs, O.
(1995)
FEBS Lett.
377,
383-389[CrossRef][Medline]
[Order article via Infotrieve] 3.
Dolly, J. O.,
and Parcej, D. N.
(1996)
J. Bioenerg. Biomembr.
28,
231-253[CrossRef][Medline]
[Order article via Infotrieve] 4.
Yu, W. F., Xu, J.,
and Li, M.
(1996)
Neuron
16,
441-453[CrossRef][Medline]
[Order article via Infotrieve] 5.
Stuhmer, W.,
Ruppersberg, J. P.,
Schroter, K. H.,
Sakmann, B.,
Stocker, M.,
Giese, K. P.,
Perschke, A.,
Baumann, A.,
and Pongs, O.
(1989)
EMBO J.
8,
3235-3244[Medline]
[Order article via Infotrieve] 6.
Hopkins, W. F.
(1998)
J. Pharmacol. Exp. Ther.
285,
1051-1060 7.
Rettig, J.,
Heinemann, S. H.,
Wunder, F.,
Lorra, C.,
Parcej, D. N.,
Dolly, J. O.,
and Pongs, O.
(1994)
Nature
369,
289-294[CrossRef][Medline]
[Order article via Infotrieve] 8.
Shi, G. Y.,
Nakahira, K.,
Hammond, S.,
Rhodes, K. J.,
Schechter, L. E.,
and Trimmer, J. S.
(1996)
Neuron
16,
843-852[CrossRef][Medline]
[Order article via Infotrieve] 9.
Akhtar, S.,
McIntosh, P.,
Bryan-Sisneros, A.,
Barratt, L.,
Robertson, B.,
and Dolly, J. O.
(1999)
Biochemistry
38,
16984-16992[CrossRef][Medline]
[Order article via Infotrieve] 10.
Shamotienko, O.,
Akhtar, S.,
Sidera, C.,
Meunier, F. A.,
Ink, B.,
Weir, M.,
and Dolly, J. O.
(1999)
Biochemistry
38,
16766-16776[CrossRef][Medline]
[Order article via Infotrieve] 11.
Dolly, J. O.,
Halliwell, J. V.,
Black, J. D.,
Williams, R. S.,
Pelchen-Matthews, A.,
Breeze, A. L.,
Mehraban, F.,
Othman, I. B.,
and Black, A. R.
(1984)
J. Physiol. Paris
79,
280-303[Medline]
[Order article via Infotrieve] 12.
Schweitz, H.,
and Moinier, D.
(1999)
Perspect. Drug Discov. Des.
15/16,
83-110 13.
Shamotienko, O. G.,
Parcej, D. N.,
and Dolly, J. O.
(1997)
Biochemistry
36,
8195-8201[CrossRef][Medline]
[Order article via Infotrieve] 14.
Coleman, S. K.,
Newcombe, J.,
Pryke, J.,
and Dolly, J. O.
(1999)
J. Neurochem.
73,
849-858[CrossRef][Medline]
[Order article via Infotrieve] 15.
Wang, F. C.,
Parcej, D. N.,
and Dolly, J. O.
(1999)
Eur. J. Biochem.
263,
230-237[Medline]
[Order article via Infotrieve] 16.
Koschak, A.,
Bugianesi, R. M.,
Mitterdorfer, J.,
Kaczorowski, G. J.,
Garcia, M. L.,
and Knaus, H. G.
(1998)
J. Biol. Chem.
273,
2639-2644 17.
Scott, V. E. S.,
Muniz, Z. M.,
Sewing, S.,
Lichtinghagen, R.,
Parcej, D. N.,
Pongs, O.,
and Dolly, J. O.
(1994)
Biochemistry
33,
1617-1623[CrossRef][Medline]
[Order article via Infotrieve] 18.
Rasband, M.,
Trimmer, J. S.,
Schwarz, T. L.,
Levinson, S. R.,
Ellisman, M. H.,
Schachner, M.,
and Shrager, P.
(1998)
J. Neurosci.
18,
36-47 19.
Rhodes, K. J.,
Strassle, B. W.,
Monaghan, M. M.,
Bekelearcuri, Z.,
Matos, M. F.,
and Trimmer, J. S.
(1997)
J. Neurosci.
17,
8246-8258 20.
Keighley, W. W.,
Newcombe, J.,
Templeton, D.,
and Treherne, J. M.
(1994)
J. Physiol. (Lond.)
480P,
68P-69P 21.
Cochran, S. M.,
and Pratt, J. A.
(1997)
Br. J. Pharmacol.
122,
256 22.
Browne, D. L.,
Brunt, E. R.,
Griggs, R. C.,
Nutt, J. G.,
Gancher, S. T.,
Smith, E. A.,
and Litt, M.
(1995)
Hum. Mol. Genet.
4,
1671-1672 23.
Adelman, J. P.,
Bond, C. T.,
Pessia, M.,
and Maylie, J.
(1995)
Neuron
15,
1449-1454[CrossRef][Medline]
[Order article via Infotrieve] 24.
Wang, H.,
Allen, M. L.,
Grigg, J. J.,
Noebels, J. L.,
and Tempel, B. L.
(1995)
Neuron
15,
1337-1347[CrossRef][Medline]
[Order article via Infotrieve] 25.
Main, M. J.,
Brown, J.,
Brown, S.,
Fraser, N. J.,
and Foord, S. M.
(1998)
FEBS Lett.
441,
6-10[CrossRef][Medline]
[Order article via Infotrieve] 26.
McIntosh, P.,
Southan, A. P.,
Akhtar, S.,
Sidera, C.,
Ushkaryov, Y.,
Dolly, J. O.,
and Robertson, B.
(1997)
Pfluegers Arch. Eur. J. Physiol.
435,
43-45[CrossRef][Medline]
[Order article via Infotrieve] 27.
Parcej, D. N.,
Scott, V. E. S.,
and Dolly, J. O.
(1992)
Biochemistry
31,
11084-11088[CrossRef][Medline]
[Order article via Infotrieve] 28.
Tytgat, J.,
Debont, T.,
Carmeliet, E.,
and Daenens, P.
(1995)
J. Biol. Chem.
270,
24776-24781 29.
Hollerer-Beitz, G.,
Schonherr, R.,
Koenen, M.,
and Heinemann, S. H.
(1999)
Pfluegers Arch. Eur. J. Physiol.
438,
141-146[CrossRef][Medline]
[Order article via Infotrieve] 30.
Varshney, A.,
and Mathew, M. K.
(2000)
Neuroreport
11,
2913-2917[Medline]
[Order article via Infotrieve] 31.
Wang, F. C.,
Bell, N.,
Reid, P.,
Smith, L. A.,
McIntosh, P.,
Robertson, B.,
and Dolly, J. O.
(1999)
Eur. J. Biochem.
263,
222-229[Medline]
[Order article via Infotrieve] 32.
Awan, K.,
and Dolly, J. O.
(1991)
Neuroscience
40,
29-39[CrossRef][Medline]
[Order article via Infotrieve] 33.
Smith, L. A.,
Reid, P. F.,
Wang, F. C.,
Parcej, D. N.,
Schmidt, J. J.,
Olson, M. A.,
and Dolly, J. O.
(1997)
Biochemistry
36,
7690-7696[CrossRef][Medline]
[Order article via Infotrieve] 34.
Imredy, J. P.,
and MacKinnon, R.
(2000)
J. Mol. Biol.
296,
1283-1294[CrossRef][Medline]
[Order article via Infotrieve] 35.
Hurst, R. S.,
Busch, A. E.,
Kavanaugh, M. P.,
Osborne, P. B.,
North, R. A.,
and Adelman, J. P.
(1991)
Mol. Pharmacol.
40,
572-576[Abstract] 36.
Stocker, M.,
Pongs, O.,
Hoth, M.,
Heinemann, S. H.,
Stuhmer, W.,
Schroter, K. H.,
and Ruppersberg, J. P.
(1991)
Proc. R. Soc. Ser. B Biol. Sci.
245,
101-107[Medline]
[Order article via Infotrieve]
37.
Gasparini, S.,
Danse, J. M.,
Lecoq, A.,
Pinkasfeld, S.,
Zinn-Justin, S.,
Young, L. C.,
de Medeiros, C. C. L.,
Rowan, E. G.,
Harvey, A. L.,
and Menez, A.
(1998)
J. Biol. Chem.
273,
25393-25403 38.
Stansfeld, C. E.,
Marsh, S. J.,
Halliwell, J. V.,
and Brown, D. A.
(1986)
Neurosci. Lett.
64,
299-304[CrossRef][Medline]
[Order article via Infotrieve] 39.
Gamkrelidze, G.,
Giaume, C.,
and Peusner, K. D.
(1998)
J. Neurosci.
18,
1449-1464 40.
Gold, M. S.,
Shuster, M. J.,
and Levine, J. D.
(1996)
J. Neurophys.
75,
2629-2646 41.
Hall, A.,
Stow, J.,
Sorensen, R.,
Dolly, J. O.,
and Owen, D.
(1994)
Br. J. Pharmacol.
113,
959-967[Medline]
[Order article via Infotrieve] 42.
D'Adamo, M. C.,
Liu, Z.,
Adelman, J. P.,
Maylie, J.,
and Pessia, M.
(1998)
EMBO J.
17,
1200-1207[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. L. Heaps, E. C. Jeffery, G. A. Laine, E. M. Price, and D. K. Bowles Effects of exercise training and hypercholesterolemia on adenosine activation of voltage-dependent K+ channels in coronary arterioles J Appl Physiol, December 1, 2008; 105(6): 1761 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Sack, O. Shamotienko, and J. O. Dolly How to Validate a Heteromeric Ion Channel Drug Target: Assessing Proper Expression of Concatenated Subunits J. Gen. Physiol., May 1, 2008; 131(5): 415 - 420. [Full Text] [PDF] |
||||
![]() |
H. M. Brew, J. X. Gittelman, R. S. Silverstein, T. D. Hanks, V. P. Demas, L. C. Robinson, C. A. Robbins, J. McKee-Johnson, S. Y. Chiu, A. Messing, et al. Seizures and Reduced Life Span in Mice Lacking the Potassium Channel Subunit Kv1.2, but Hypoexcitability and Enlarged Kv1 Currents in Auditory Neurons J Neurophysiol, September 1, 2007; 98(3): 1501 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. X. Gittelman and B. L Tempel Kv1.1-Containing Channels Are Critical for Temporal Precision During Spike Initiation J Neurophysiol, September 1, 2006; 96(3): 1203 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khavandgar, J. T. Walter, K. Sageser, and K. Khodakhah Kv1 channels selectively prevent dendritic hyperexcitability in rat Purkinje cells J. Physiol., December 1, 2005; 569(2): 545 - 557. [Abstract] [Full Text] [PDF] |
||||